In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program

Cefiderocol is a siderophore-conjugated cephalosporin with broad activity against Gram-negative (GN) bacteria, including carbapenem-resistant Enterobacterales (CRE), Pseudomonas aeruginosa, Acinetobacter spp., and Stenotrophomonas maltophilia. Cefiderocol was approved by the FDA for treatment of com...

Descripción completa

Detalles Bibliográficos
Autores principales: Shortridge, Dee, Streit, Jennifer M., Mendes, Rodrigo, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045385/
https://www.ncbi.nlm.nih.gov/pubmed/35262394
http://dx.doi.org/10.1128/spectrum.02712-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045385/
https://www.ncbi.nlm.nih.gov/pubmed/35262394
http://dx.doi.org/10.1128/spectrum.02712-21

Ejemplares similares